Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|---|
| 1 |
1
Johnson & Johnson
JNJ
$612B
| 4,698 | +37 | +0.8% | $457B |
|
| 2 |
2
Abbott
ABT
$178B
| 2,982 | -134 | -4% | $125B |
|
| 3 |
3
Stryker
SYK
$108B
| 2,267 | -45 | -2% | $97.2B |
|
| 4 |
4
Intuitive Surgical
ISRG
$148B
| 2,258 | -64 | -3% | $122B |
|
| 5 |
5
Medtronic
MDT
$121B
| 2,146 | -106 | -5% | $86.8B |
|
| 6 |
6
Danaher
DHR
$158B
| 2,118 | -66 | -3% | $110B |
|
| 7 |
7
Boston Scientific
BSX
$62.3B
| 1,487 | -196 | -12% | $57.3B |
|
| 8 |
8
Becton Dickinson
BDX
$51.5B
| 1,445 | -30 | -2% | $41.2B |
|
| 9 |
9
Edwards Lifesciences
EW
$49.8B
| 1,338 | +46 | +4% | $47.1B |
|
| 10 |
10
GE HealthCare
GEHC
$30.9B
| 1,233 | -42 | -3% | $25.2B |
|
| 11 |
11
Waters Corp
WAT
$42.9B
| 1,185 | +7 | +0.6% | $37.3B |
|
| 12 |
12
Agilent Technologies
A
$49.1B
| 1,135 | +60 | +6% | $34.6B |
|
| 13 |
13
DuPont de Nemours
DD
$17.4B
| 1,132 | -102 | -8% | $14.4B |
|
| 14 |
14
Quest Diagnostics
DGX
$25.8B
| 1,111 | +42 | +4% | $22.2B |
|
| 15 |
15
Roper Technologies
ROP
$36.9B
| 1,083 | -66 | -6% | $34.6B |
|
| 16 |
16
Labcorp
LH
$25.7B
| 1,060 | +23 | +2% | $22.2B |
|
| 17 |
17
DexCom
DXCM
$31.5B
| 976 | +14 | +1% | $26B |
|
| 18 |
18
Zimmer Biomet
ZBH
$17.5B
| 912 | -6 | -0.7% | $17.1B |
|
| 19 |
19
ResMed
RMD
$33.1B
| 891 | -54 | -6% | $19.4B |
|
| 20 |
20
Solventum
SOLV
$14.9B
| 885 | 0 | 0% | $9.84B |
|
| 21 |
21
Natera
NTRA
$56.9B
| 850 | +83 | +11% | $37.2B |
|
| 22 |
22
Steris
STE
$21.2B
| 839 | -7 | -0.8% | $20.1B |
|
| 23 |
23
Nordson
NDSN
$18.3B
| 757 | +43 | +6% | $12.9B |
|
| 24 |
24
Insulet
PODD
$9.29B
| 731 | -57 | -7% | $10.9B |
|
| 25 |
25
Baxter International
BAX
$12.8B
| 687 | +24 | +4% | $11.9B |
|